Rabies Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Methods (Fluorescent Antibody Test, Histologic, Serology), By Technology (ELISA, PCR), And Segment Forecasts, 2019 - 2025

Published: Feb, 2019 | Pages: 110 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global rabies diagnostics market size is expected to reach USD 2.03 billion by 2025 and is projected to expand at a CAGR of 4.1% during the forecast period, according to a new report by Grand View Research, Inc. Development of various diagnostic assays ranging from detection of virus presence to final confirmation of infection helps launch effective disease control programs. This factor is anticipated to drive the market growth. These assays aid in defining epidemiologic patterns of the disease and thereby deliver appropriate information for designing the control and eradication programs. These programs have boosted the market growth by increasing the rate at which testing kits are adopted.

For example, in June 2018, the World Health Organization (WHO), the World Organization for Animal Health (OIE), the Global Alliance for Rabies Control (GARC), and the Food and Agriculture Organization of the United Nations (FAO) entered into a partnership for a plan, The United Against Rabies Collaboration. This plan aims for rabies prevention and management and empowering the under-served populations in afflicted countries.

Furthermore, the state and public health officials of the Department of Public Health and Human Services (DPHHS) along with the Department of Livestock of Montana, U.S., deal with awareness pertaining to the risk of virus exposure. They are engaged in training the population about various aspects of disease management including prevention, detection, and available treatment modes. Such initiatives are projected to create growth opportunities for the rabies diagnostics market during the forecast period.

Further key findings from the report suggest:

• Fluorescent Antibody Test (FAT) held the largest market share in terms of revenue owing to the high usage and recommendation by the WHO. Great specificity, as compare to other conventional tests such as serology and histology tests bodes well for the adoption of these tests

• Amplification methods are expected to supplant a major portion of conventional methods, primarily due to several advantages associated with the usage

• Currently, major products deploy ELISA/immunohistochemistry techniques, resulting into a larger revenue share of this segment

• High prevalence of the disease in India and China coupled with growing government support has contributed to the dominance of Asia market over other regions

• Since, most of the countries in Europe are designated as rabies free jurisdictions, the Europe market is anticipated to grow at the slowest pace over the forecast period

• Bio-Rad Laboratories, Inc.; Merck KGaA; Aviva Systems Biology Corporation; and Creative Diagnostics are some of the key entities in the rabies testing market. The companies engage in developing products for rabies eradication programs.

 Table of Contents

Chapter 1 Executive Summary
                   1.1 Market Snapshot

Chapter 2 Research Methodology
                   2.1 Information Procurement
                       2.1.1 Purchased Database
                       2.1.2 GVR's Internal Database
                   2.2 Data Analysis
                   2.3 Market Formulation & Validation
                   2.4 Approaches for Market Estimation
                       2.4.1 Approach 1: Commodity Flow & Bottom Up Approach
                       2.4.2 Approach 2: Top Down and Parent Market Analysis

Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Segmentation & Scope
                       3.1.1 Market driver analysis
                           3.1.1.1 High prevalence of rabies coupled with increase in number of dog bites
                           3.1.1.2 Supportive government initiatives & laws
                           3.1.1.3 Presence of research funding programs
                       3.1.2 Market restraint analysis
                           3.1.2.1 Lack of awareness about advanced technologies
                           3.1.2.2 High cost and result inconsistency associated with rabies diagnosis
                   3.2 Penetration & Growth Prospect Mapping For Method, 2017
                   3.3 Global Rabies Diagnostics Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                   3.4 Industry Analysis - Porter's

Chapter 4 Global Rabies Diagnostics Market Categorization: Diagnostic Method Estimates & Trend Analysis
                   4.1 Global Rabies Diagnostics Market: Diagnostic Method Movement Analysis
                   4.2 Fluorescent antibody test (FAT)
                       4.2.1 Global Fluorescent Antibody Test (FAT) market, 2014 - 2025 (USD Million)
                   4.3 Immunohistochemical Test
                       4.3.1 Global immunohistochemical test market, 2014 - 2025 (USD Million)
                   4.4 Amplification Methods
                       4.4.1 Global amplification methods market, 2014 - 2025 (USD Million)
                   4.5 Histologic Examination
                       4.5.1 Global histologic examination market, 2014 - 2025 (USD Million)
                   4.6 Serology Tests
                       4.6.1 Global serology tests market, 2014 - 2025 (USD Million)

Chapter 5 Global Rabies Diagnostics Market Categorization: Technology Estimates & Trend Analysis
                   5.1 Global Rabies Diagnostics Market: Technology Movement Analysis
                   5.2 ELISA/Immunohistochemistry
                       5.2.1 Global ELISA/immunohistochemistry-based rabies diagnostic/testing market, 2014 - 2025 (USD Million)
                   5.3 Chromatography Techniques
                       5.3.1 Global chromatography techniques-based rabies diagnostic/testing market, 2014 - 2025 (USD Million)
                   5.4 PCR
                       5.4.1 Global PCR-based rabies diagnostic/testing market, 2014 - 2025 (USD Million)
                   5.5 Other Technologies
                       5.5.1 Global other technology -based rabies diagnostic/testing market, 2014 - 2025 (USD Million)

Chapter 6 Global Rabies Diagnostics Market Categorization: Regional Estimates & Trend Analysis, by Diagnostic Method and Technology
                   6.1 Global Rabies Diagnostics Market Share By Regional, 2017 & 2025
                   6.2 North America
                       6.2.1 North America Rabies Diagnostics market, 2014 - 2025 (USD Million)
                       6.2.2 U.S.
                           6.2.2.1 U.S. rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.2.2.2 U.S. rabies diagnostics market, by technology, 2014 - 2025 (USD Million)
                       6.2.3 Canada
                           6.2.3.1 Canada rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.2.3.2 Canada rabies diagnostics market, by technology, 2014 - 2025 (USD Million)
                   6.3 Europe
                       6.3.1 Europe rabies diagnostics market, 2014 - 2025 (USD Million)
                       6.3.2 U.K.
                           6.3.2.1 U.K. rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.3.2.2 U.K. rabies diagnostics market, by technology, 2014 - 2025 (USD Million)
                       6.3.3 Spain
                           6.3.3.1 Spain rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.3.3.2 Spain rabies diagnostics market, by technology, 2014 - 2025 (USD Million)
                   6.4 Asia Pacific
                       6.4.1 Asia Pacific rabies diagnostics market, 2014 - 2025 (USD Million)
                       6.4.2 India
                           6.4.2.1 India rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.4.2.2 India rabies diagnostics market, by technology, 2014 - 2025 (USD Million)
                       6.4.3 China
                           6.4.3.1 China rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.4.3.2 China rabies diagnostics market, by technology, 2014 - 2025 (USD Million)
                       6.4.4 Indonesia
                           6.4.4.1 Indonesia rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.4.4.2 Indonesia rabies diagnostics market, by technology, 2014 - 2025 (USD Million)
                   6.5 Latin America
                       6.5.1 Latin America rabies diagnostics market, 2014 - 2025 (USD Million)
                       6.5.2 Brazil
                           6.5.2.1 Brazil rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.5.2.2 Brazil rabies diagnostics market, by technology, 2014 - 2025 (USD Million)
                   6.6 MEA
                       6.6.1 MEA rabies diagnostics market, 2014 - 2025 (USD Million)
                       6.6.2 South Africa
                           6.6.2.1 South Africa rabies diagnostics market, by diagnostic method, 2014 - 2025 (USD Million)
                           6.6.2.2 South Africa rabies diagnostics market, by technology, 2014 - 2025 (USD Million)

Chapter 7 Global Rabies Diagnostics Market: Competitive Landscape
                   7.1 Strategy Framework
                   7.2 Company Profiles
                       7.2.1 Bio-Rad Laboratories, Inc.
                           7.2.1.1 Company overview
                           7.2.1.2 Financial performance
                           7.2.1.3 Product benchmarking
                           7.2.1.4 Strategic initiatives
                       7.2.2 Merck KGaA
                           7.2.2.1 Company overview
                           7.2.2.2 Financial performance
                           7.2.2.3 Product benchmarking
                           7.2.2.4 Strategic initiatives
                       7.2.3 Aviva Systems Biology Corporation
                           7.2.3.1 Company overview
                           7.2.3.2 Financial performance
                           7.2.3.3 Product benchmarking
                           7.2.3.4 Strategic initiatives
                       7.2.4 Creative Diagnostics
                           7.2.4.1 Company overview
                           7.2.4.2 Financial performance
                           7.2.4.3 Product benchmarking
                           7.2.4.4 Strategic initiatives
                       7.2.5 Demeditec Diagnostics GmbH
                           7.2.5.1 Company overview
                           7.2.5.2 Financial performance
                           7.2.5.3 Product benchmarking
                           7.2.5.4 Strategic initiatives
                       7.2.6 Abbexa Ltd.
                           7.2.6.1 Company overview
                           7.2.6.2 Financial performance
                           7.2.6.3 Product benchmarking
                           7.2.6.4 Strategic initiatives
                       7.2.7 Norgen Biotek Corp.
                           7.2.7.1 Company overview
                           7.2.7.2 Financial performance
                           7.2.7.3 Product benchmarking
                           7.2.7.4 Strategic initiatives
                       7.2.8 BioNote, Inc.
                           7.2.8.1 Company overview
                           7.2.8.2 Financial performance
                           7.2.8.3 Product benchmarking
                           7.2.8.4 Strategic initiatives
                       7.2.9 Express Biotech International Inc.
                           7.2.9.1 Company overview
                           7.2.9.2 Financial performance
                           7.2.9.3 Product benchmarking
                           7.2.8.4 Strategic initiatives
                       7.2.10 MyBioSource.com.
                           7.2.10.1 Company overview
                           7.2.10.2 Financial performance
                           7.2.10.3 Product benchmarking
                           7.2.10.4 Strategic initiatives

List of Tables

TABLE 1 Incidence of rabies in India every year
TABLE 2 Trend of rabies and dog bites in Techiman, Ghana, 2011 - 2016.
TABLE 3 Percentage of cross species transmission among terrestrial mammals in Iowa, 2017.
TABLE 4 Rate of cross species transmission among terrestrial mammals in U.S.
TABLE 5 Costs of Rabies Control: An Economic Calculation Method Applied to Flores Island
TABLE 6 North America rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 7 North America rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 8 U.S. rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 9 U.S. rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 10 Canada rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 11 Canada rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 12 Europe rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 13 Europe rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 14 U.K. rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 15 U.K. rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 16 Spain rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 17 Spain rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 18 Asia Pacific rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 19 Asia Pacific rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 20 India rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 21 India rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 22 China rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 23 China rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 24 Indonesia rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 25 Indonesia rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 26 Latin America rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 27 Latin America rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 28 Brazil rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 29 Brazil rabies diagnostics market market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 30 The following table compares the incidence of human rabies in various countries of Middle East:
TABLE 31 MEA rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 32 MEA rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 33 South Africa rabies diagnostics market estimates & forecasts, by diagnostic method, 2014 - 2025 (USD Million)
TABLE 34 South Africa rabies diagnostics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market snapshot
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Number of dog bites cases in sub-Saharan Africa, 2013 to 2015
FIG. 12 Expenditure of GARC in several programmatic activities
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Penetration & growth prospect mapping for method, 2017
FIG. 15 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 16 Porter's Five Forces Analysis
FIG. 17 Global rabies diagnostics market: Diagnostic method outlook key takeaways
FIG. 18 Global rabies diagnostics market: Diagnostic method movement analysis
FIG. 19 Global FAT market, 2014 - 2025 (USD Million)
FIG. 20 Global immunohistochemical test market, 2014 - 2025 (USD Million)
FIG. 21 Global amplification methods market, 2014 - 2025 (USD Million)
FIG. 22 Global histologic examination market, 2014 - 2025 (USD Million)
FIG. 23 Global serology tests market, 2014 - 2025 (USD Million)
FIG. 24 Global rabies diagnostics market: Technology outlook key takeaways
FIG. 25 Global rabies diagnostics market: Technology movement analysis
FIG. 26 Global ELISA/immunohistochemistry-based rabies diagnostic/testing market, 2014 - 2025 (USD Million)
FIG. 27 Global chromatography techniques-based rabies diagnostic/testing market, 2014 - 2025 (USD Million)
FIG. 28 Global PCR-bad rabies diagnostic/testing market, 2014 - 2025 (USD Million)
FIG. 29 Global other technology -based rabies diagnostic/testing market, 2014 - 2025 (USD Million)
FIG. 30 Regional market place: Key takeaway
FIG. 31 Rate of human deaths due to rabies, by region (per million population)
FIG. 32 Global rabies diagnostics market: Regional outlook, 2017 & 2025
FIG. 33 North America rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 34 Percentage of Rabid Animals in U.S. in 2015 (%)
FIG. 35 U.S. rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 36 Number of confirmed rabies cases in Canadian states, 2017
FIG. 37 Canada rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 38 Europe rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 39 U.K. rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 40 Total cases of animal rabies declared Ceuta and Melilla, Spain, 2012-2016
FIG. 41 Spain rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 42 Mortality rate in human rabies cases in Asia Pacific countries, per 100000
FIG. 43 Asia Pacific rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 44 Percentage of Human Rabies Deaths in Rural and Urban Areas
FIG. 45 India rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 46 Rabies deaths and exposed population according to gender in China, from 2005 to 2011
FIG. 47 China rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 48 Indonesia rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 49 Number of Human rabies Cases in Latin American Countries, 2014 - 2016
FIG. 50 Latin America rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 51 Brazil rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 52 MEA rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 53 South Africa rabies diagnostics market, 2014 - 2025 (USD Million)
FIG. 54 Strategy framework